TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11914444

Group type: EXPERIMENTAL
Intervention: Full intervention (assessment, personalized self-study feedback, six face-to-face sessions)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Partial intervention (self-help group with assessment and personalized feedback by mail)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Full intervention (HMO subsample)
Number of subjects: 501
Study: 9821996

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide administered to patients receiving norepinephrine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Inhaled nitric oxide administered to patients not receiving norepinephrine
Number of subjects: 27
Study: 9051541

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg (Group MH)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Midazolam 0.035 mg/kg (Group ML)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (Group PL)
Number of subjects: 11
Study: 2527316

Group type: EXPERIMENTAL
Intervention: Prophylactic closed suction drainage on one side of the groin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Closure without drainage on the contralateral side of the groin
Number of subjects: 50
Study: 1276560

Group type: EXPERIMENTAL
Intervention: Medicine group (antidepressive drug treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (placebo treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Natural Process group (no treatment)
Number of subjects: 0
Study: 30738059

Group type: EXPERIMENTAL
Intervention: Piezosurgery device (group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional method (group A)
Number of subjects: 20
Study: 28409744

Group type: EXPERIMENTAL
Intervention: multiple‐modality exercise (M2)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: multiple‐modality plus mind‐motor exercise (M4)
Number of subjects: 58
Study: 26152412

Group type: EXPERIMENTAL
Intervention: Imidacloprid/Flumethrin Collar (Seresto)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fipronil/(S)-Methoprene/Eprinomectin/Praziquantel Spot-on (Broadline)
Number of subjects: 24
Study: 23209098

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) for SSTI
Number of subjects: 109
Study: 21421014

Group type: EXPERIMENTAL
Intervention: GLP‐2, 1600 μg subcutaneously (SC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 8
Study: 19333166

Group type: EXPERIMENTAL
Intervention: Tramadol (50 mg, 3 times daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (1 tablet, 3 times daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16943675

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with standardized latex extract
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15157351

Group type: EXPERIMENTAL
Intervention: UPBEAT Program (interdisciplinary mental health care management program)
Number of subjects: 2637

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2637

Group type: EXPERIMENTAL
Intervention: UPBEAT Program
Number of subjects: 2637
Study: 11380295

Group type: EXPERIMENTAL
Intervention: MVA (manual vacuum aspiration)
Number of subjects: 200

Group type: COMPARATOR
Intervention: VA (conventional vacuum aspiration)
Number of subjects: 200
Study: 9230243

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg twice daily for 6 months
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 262
Study: 8106830

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Subtherapeutic group (control)
Number of subjects: 15
Study: 3318371

Group type: EXPERIMENTAL
Intervention: DPI 201-106 (80 mg and 100 mg)
Number of subjects: 15
Study: 29705466

Group type: EXPERIMENTAL
Intervention: Yoga Group (YG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pamphlet Group (PG)
Number of subjects: 30
Study: 27737685

Group type: EXPERIMENTAL
Intervention: Community-based multidisciplinary rehabilitation intervention
Number of subjects: 620

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 620
Study: 24229842

Group type: EXPERIMENTAL
Intervention: Manner of drinking (MOD)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Serious harm reduction (SHR)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Stopping/limiting drinking (SLD)
Number of subjects: 338
Study: 22866998

Group type: EXPERIMENTAL
Intervention: CBT-based PAC intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: PEP-based PAC intervention
Number of subjects: 0
Study: 20386077

Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir 900/100 mg once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: darunavir/ritonavir 600/100 mg twice daily
Number of subjects: 30
Study: 18561543

Group type: EXPERIMENTAL
Intervention: Novel words with English plural inflection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Novel words without English plural inflection
Number of subjects: 24
Study: 16032944

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Eludril) irrigation associated with scaling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (Dakin Cooper) irrigation associated with scaling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scaling alone
Number of subjects: 0
Study: 12492907

Group type: EXPERIMENTAL
Intervention: Triclosan solubilized in alcohol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Triclosan solubilized in oil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Triclosan solubilized in uncharged detergent
Number of subjects: 19

Group type: COMPARATOR
Intervention: Triclosan solubilized in chromophor
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Triclosan solubilized in sodium lauryl sulphate, propylene glycol and water
Number of subjects: 19
Study: 10063942

Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg twice daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 7569093

Group type: EXPERIMENTAL
Intervention: Iopentol 300 mg/ml
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iohexol 300 mg/ml
Number of subjects: 60
Study: 2208249

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 352097

Group type: EXPERIMENTAL
Intervention: Prednisone (P)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Prednisone (P) + Azathioprine (A)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Prednisone (P) + Azathioprine (A) + Cyclophosphamide (C)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 29
Study: 31343263

Group type: EXPERIMENTAL
Intervention: RNA extracted from PAXgene Blood RNA tubes stored for 1 month
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: RNA extracted from PAXgene Blood RNA tubes stored for 1 year
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: RNA extracted from PAXgene Blood RNA tubes stored for 2 years
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: RNA extracted from PAXgene Blood RNA tubes stored for 3 years
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: RNA extracted from PAXgene Blood RNA tubes stored for 6 years
Number of subjects: 300
Study: 28505367

Group type: EXPERIMENTAL
Intervention: Health Information Exchange (HIE) access during medication reconciliation
Number of subjects: 381

Group type: COMPARATOR
Intervention: Usual care (without HIE access)
Number of subjects: 381
Study: 26271132

Group type: EXPERIMENTAL
Intervention: Acupuncture at Neiguan (PC 6), applied once every two days, 3 days a week for 4 weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Medication group (basic medication without acupuncture intervention).
Number of subjects: 30
Study: 23561865

Group type: EXPERIMENTAL
Intervention: Centering Principle of Pilates Method (performed by LBPG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Centering Principle of Pilates Method (performed by CG)
Number of subjects: 18
Study: 21749209

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor and autologous bone marrow-derived stem/progenitor cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20467641

Group type: EXPERIMENTAL
Intervention: 2 g amoxicillin
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 16826094

Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic (Ce/Ce) implant
Number of subjects: 61

Group type: COMPARATOR
Intervention: Metal-on-polyethylene (PE) implant
Number of subjects: 61
Study: 14616428

Group type: EXPERIMENTAL
Intervention: Diltiazem co-treatment (30 mg or 60 mg twice daily depending on weight)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 11097144

Group type: EXPERIMENTAL
Intervention: Grapefruit juice pretreatment with oral scopolamine 0.5 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous scopolamine 0.5 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Scopolamine administration (all routes)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Scopolamine administration
Number of subjects: 14
Study: 9505992

Group type: EXPERIMENTAL
Intervention: Microemulsion oral solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Microemulsion soft gelatin capsule
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional oral solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Microemulsion capsule (200, 400, 600 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Microemulsion capsule (400 mg after a fat-rich meal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All dose levels of microemulsion formulation
Number of subjects: 20
Study: 7504141

Group type: EXPERIMENTAL
Intervention: Bepridil hydrochloride
Number of subjects: 23
Study: 3548587

Group type: EXPERIMENTAL
Intervention: Vibratory stimulation at 10, 100, and 200 Hz
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Larger probe
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Smaller probe
Number of subjects: 96
Study: 30824635

Group type: EXPERIMENTAL
Intervention: IV golimumab (GOL) 2 mg/kg
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo (crossover to GOL at weeks 16, 20, and every 8 weeks thereafter)
Number of subjects: 208
Study: 29369177

Group type: EXPERIMENTAL
Intervention: Virtual interface
Number of subjects: 65

Group type: COMPARATOR
Intervention: Real interface
Number of subjects: 65
Study: 26597577

Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 24 hours after surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: No cold therapy
Number of subjects: 30
Study: 25230144

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22775354

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 600 mg evening (pm)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 600 mg morning (am)/600 mg pm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 1200 mg pm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 600 mg am/1200 mg pm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 600 mg am/1800 mg pm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER 1200 mg am/1800 mg pm
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gabapentin-ER (all doses)
Number of subjects: 124
Study: 20159130

Group type: EXPERIMENTAL
Intervention: Actual Reality task (internet-based assessment of purchasing airline tickets)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Self-report measures (quality of life and functional status questionnaires)
Number of subjects: 39
Study: 16352299

Group type: EXPERIMENTAL
Intervention: Tiropramide (100 mg dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control formulation of Tiropramide (100 mg dose)
Number of subjects: 18
Study: 15257956

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: OFF-models
Number of subjects: 0
Study: 11565838

Group type: EXPERIMENTAL
Intervention: Cloned melanoma antigen-specific T lymphocytes
Number of subjects: 23

Group type: COMPARATOR
Intervention: IL-2 (125,000 IU/kg subcutaneously daily for 12 days)
Number of subjects: 23

Group type: COMPARATOR
Intervention: IL-2 (720,000 IU/kg intravenously every 8 h for 4 days)
Number of subjects: 23
Study: 10169297

Group type: EXPERIMENTAL
Intervention: Video group (n = 270)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Video + self-help group (n = 232)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Routine care (n = 255)
Number of subjects: 255
Study: 8099731

Group type: EXPERIMENTAL
Intervention: Autologous Stem Cell Transplantation (ASCT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Chemotherapy (CT)
Number of subjects: 77
Study: 3578566

Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0
Study: 28414254

Group type: EXPERIMENTAL
Intervention: Pressure Ulcer Prevention Program (lifestyle-based treatment administered by healthcare professionals, largely via in-home visits and phone contacts)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Randomized control group (standard care)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Nonrandomized control group (standard care)
Number of subjects: 166
Study: 28886221

Group type: EXPERIMENTAL
Intervention: Improved version of the tool mark comparison algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original tool mark comparison algorithm
Number of subjects: 0
Study: 27258530

Group type: EXPERIMENTAL
Intervention: Modified Beck Depression Inventory (BDI)-II administered to adults randomly selected from the community (n=221)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Caregivers of adolescents affected by HIV (n=77)
Number of subjects: 298
Study: 23955468

Group type: EXPERIMENTAL
Intervention: FraTrix intervention applied over 9 months during three facilitated team sessions.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FraTrix intervention practices reporting of patient safety incidents.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group practices (not specified in detail).
Number of subjects: 60
Study: 22627027

Group type: EXPERIMENTAL
Intervention: Independent clinical expert committee review of medical files
Number of subjects: 50

Group type: COMPARATOR
Intervention: Death certificates
Number of subjects: 50
Study: 20447532

Group type: EXPERIMENTAL
Intervention: Copeptin and troponin T (TnT) combined measurement on admission
Number of subjects: 1386
Study: 18926212

Group type: EXPERIMENTAL
Intervention: Routine bedside placement of a preformed Silastic spring‐loaded silo
Number of subjects: 54

Group type: COMPARATOR
Intervention: Primary closure
Number of subjects: 54
Study: 17806018

Group type: EXPERIMENTAL
Intervention: Preservation of the azygos vein (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Classical approach with ligation of the azygos vein (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study: 12841925

Group type: EXPERIMENTAL
Intervention: 0.05% azelastine eye drops, twice daily for 6 weeks
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Open-label levocabastine, twice daily for 6 weeks
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 10989958

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (ET-1) infusion at 20 ng/min x kg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endothelin-3 (ET-3) infusion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 7
Study: 9149659

Group type: EXPERIMENTAL
Intervention: Trans-fatty acids (top quintile intake, median = 6.2 g/day)
Number of subjects: 21930

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids from fish (highest quintile intake)
Number of subjects: 21930

Group type: EXPERIMENTAL
Intervention: Saturated or cis‐monounsaturated fatty acids, linoleic or linolenic acid, or dietary cholesterol
Number of subjects: 21930

Group type: EXPERIMENTAL
Intervention: All major coronary events
Number of subjects: 21930
Study: 8114055

Group type: EXPERIMENTAL
Intervention: Individual basis administered by physician‐nurse teams (PN)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Group basis from a team of paramedical professionals (PP)
Number of subjects: 52
Study: 3534198

Group type: EXPERIMENTAL
Intervention: Glycine-based oral rehydration solution (glycine-ORS)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard oral rehydration solution (ORS)
Number of subjects: 143
Study: 31432380

Group type: EXPERIMENTAL
Intervention: Video Interaction Project (VIP) intervention delivered in tandem with pediatric well-child visits.
Number of subjects: 403
Study: 29675616

Group type: EXPERIMENTAL
Intervention: ado-trastuzumab emtansine (T-DM1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: capecitabine-plus-lapatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: T-DM1
Number of subjects: 0
Study: 26892210

Group type: EXPERIMENTAL
Intervention: ART restorations plus petroleum jelly (PJ)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: bilayer‐ART restorations plus petroleum jelly (PJ)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: ART restorations plus nanofilled coating for GIC (NC)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: bilayer‐ART restorations plus nanofilled coating (NC)
Number of subjects: 389
Study: 24531083

Group type: EXPERIMENTAL
Intervention: NSAID-GGA group (75 mg/day diclofenac sodium and 150 mg/day GGA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: NSAID-FAM group (75 mg/day diclofenac sodium and 20 mg/day famotidine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: NSAID-GGA group
Number of subjects: 30
Study: 24327533

Group type: EXPERIMENTAL
Intervention: Bilateral coronoid hyperplasia treatment group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 20571299

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogens in COCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progestagens in COCs
Number of subjects: 0
Study: 19022973

Group type: EXPERIMENTAL
Intervention: Zinc (10-mg tablets daily until discharge)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo (daily until discharge)
Number of subjects: 550
Study: 16649407

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methione (SAMe) 500mg twice daily in slow running infusion for twelve days, ongoing oral 500 mg twice daily until delivery
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 3 x 250 mg daily
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combined therapy with both drugs (SAMe and UDCA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (SAMe monotherapy)
Number of subjects: 78
Study: 12794404

Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline solution (2400 mOsm/kg/H(2)O)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20% mannitol (1160 mOsm/kg/H(2)O)
Number of subjects: 20
Study: 11082356

Group type: EXPERIMENTAL
Intervention: Pulmonary autograft
Number of subjects: 74

Group type: COMPARATOR
Intervention: Aortic homograft
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 4-month-old autograft
Number of subjects: 74
Study: 9001061

Group type: EXPERIMENTAL
Intervention: Simplified hygiene protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard hygiene protocol
Number of subjects: 30
Study: 1386065

Group type: COMPARATOR
Intervention: Formula A (corn oil-based, low in omega-3)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Formula B (soy oil-based, ample alpha-linolenic acid)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Formula C (supplemented with alpha-linolenic acid and marine oils)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Human milk (naturally containing omega-3)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intrauterine nutrition
Number of subjects: 81
Study: 6588485

Group type: EXPERIMENTAL
Intervention: Metronidazole (1500 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tinidazole (1600 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hydroxy-metronidazole
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hydroxy-tinidazole
Number of subjects: 16
Study: 30580680

Group type: EXPERIMENTAL
Intervention: Intensive BP treatment (systolic BP target, <120 mm Hg)
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Standard BP treatment (systolic BP target, <140 mm Hg)
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Intensive BP treatment
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Standard BP treatment
Number of subjects: 1397
Study: 28423235

Group type: EXPERIMENTAL
Intervention: PEG‐asparaginase biweekly
Number of subjects: 130

Group type: COMPARATOR
Intervention: Six‐week PEG‐asparaginase intervals
Number of subjects: 130
Study: 25708187

Group type: EXPERIMENTAL
Intervention: Active rTMS (15 Hz, 30 min once a day for 5 days at 80% resting motor threshold)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo rTMS
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 11
Study: 23888450

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) ointment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Vaseline ointment (control)
Number of subjects: 240
Study: 21444807

Group type: EXPERIMENTAL
Intervention: High-dose CNTF implant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose CNTF implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined low-dose/sham group
Number of subjects: 0
Study: 19802659

Group type: EXPERIMENTAL
Intervention: Fondaparinux sodium (FPX) 2.5 mg/day for 14 days
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (non-FPX)
Number of subjects: 76